International Biotechnology Trust’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

International Biotechnology Trust’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,653	Closed	-$203K	–	58
2020 Q4	$203K	Hold	5,653	–	–	0.06%	52
2020 Q3	$210K	Hold	5,653	–	–	0.07%	52
2020 Q2	$187K	Hold	5,653	–	–	0.06%	53
2020 Q1	$183K	Hold	5,653	–	–	0.08%	55
2019 Q4	$188K	Buy	+5,653	New	+$169K	0.07%	62

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

International Biotechnology Trust's ZEAL Position: Q1 2021 in Review

International Biotechnology Trust sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2021, closing a stake of 5,653 shares — an estimated $203K sold.

International Biotechnology Trust first reported a position in ZEAL in Q4 2019 and held it in 5 quarters. The position peaked at $210K in Q3 2020. 16 funds tracked by Wall St. Rank hold ZEAL as of Q1 2021.

International Biotechnology Trust reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2021 after selling out during the quarter.
International Biotechnology Trust sold 5,653 Zealand Pharma A/S American Depositary Shares shares in Q1 2021, an estimated $203K.
International Biotechnology Trust first reported a position in Zealand Pharma A/S American Depositary Shares in Q4 2019 and held it in 5 quarters.
International Biotechnology Trust's Zealand Pharma A/S American Depositary Shares position peaked at $210K in Q3 2020.
16 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2021.

Based on International Biotechnology Trust's 13F filing for Q1 2021, filed 17 May 2021.